在脊椎关节炎中IL-33是缺失的关键
Frank Verhoeven1, Dalil Hannani2, Céline Demougeot3
1Université Marie et Louis Pasteur, EFS, INSERM UMR 1098 RIGHT, Besançon F-25000, France; Rhumatologie, CHU de Besançon, Besançon, France; Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, 38000 Grenoble, France.
Autoimmunity reviews
|October 24, 2025
概括
介质素-33 (IL-33) 涉及到脊椎关节炎 (SpA) 炎症和骨变化. 准IL-33/ST2通路对治疗SpA和预防关节损伤有很大的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 病理生理学 病理生理学
背景情况:
- 介质素-33 (IL-33) 是组织损伤时释放的警示蛋白,越来越多地与炎症性疾病如脊髓关节炎 (SpA) 相关.
- IL-33/ST2通路影响免疫细胞激活,包括2型先天性淋巴细胞,Th17反应和巨细胞极化,有助于SpA的发病.
- IL-33在肌肉骨 (肠炎,突炎,轴性炎症) 和关节外 (肠道,皮肤,眼睛) 的SPA表现中发挥作用.
研究的目的:
- 审查IL-33/ST2通路在脊椎关节炎病理生理学的新兴作用.
- 讨论针对IL-33治疗SPA的治疗潜力,包括它对炎症和骨代谢的影响.
主要方法:
- 对临床前研究和有关IL-33/ST2轴在脊椎关节炎中的现有文献的综述.
- 在SPA的背景下分析IL-33在炎症和骨代谢中的双重作用.
主要成果:
- 针对IL-33/ST2轴的临床前研究表明,关节炎的严重程度,关节损伤和炎症减少.
- IL-33表现出双重作用,可能抑制骨质细胞分化或通过亲骨质性巨细胞促进病态骨形成.
- IL-33调节提供了一种潜在的策略来控制炎症并影响结构结果,包括SpA.新骨的形成.
结论:
- IL-33/ST2通路是SpA发展和进展的一个重要因素.
- 向IL-33是一个有前途的治疗途径,可能补充现有的治疗方法,如抗TNFα和抗IL-17疗法.
- 调节IL-33可以通过减少炎症和改变骨重塑过程,在SPA中提供双重好处.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
484
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
484
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
483
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
483
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K


